View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


Rational Combinations 360° Educational Partner Hosts 5th Annual Cancer Immunotherapy Month in June

  • June 15, 2017

  • Cancer Immunotherapy Month, organized by The Cancer Research Institute (CRI), occurs every June and aims to increase public awareness of cancer immunotherapy, clinical trials and research to help make curing cancer a reality.

    “Advances in immunotherapy research have brought us to a tipping point in the transformation of cancer treatment,” said Dr Jill O’Donnell-Tormey, IO360° speaker and CEO/director of scientific affairs at CRI. “But these advances have created an urgent need to equip cancer patients and their caregivers with knowledge about immunotherapy so that they can make the most informed decisions when discussing their treatment options with their oncologists.”

    As part of Cancer Immunotherapy Month, CRI—along with Rational Combinations 360° educational partner, Society of Immunotherapy of Cancer (SITC)—host several educational programs to help raise awareness. Other cancer research organizations also support this effort by hosting their own programs.

    CRI’s Chairman of the Cancer Immunotherapy Consortium, Dr Axel Hoos, GSK, along with Dr Patrick Hwu, MD Anderson, and Dr Ian McCaffery, Corvus Pharma, present the 2nd annual Rational Combinations 360° program addressing business, clinical and scientific advancement in IO combination strategies to fight a wider range of cancers, June 28-29 in NYC.

    Learn more about Rational Combinations 360°.

    View CRI’s Cancer Immunotherapy Month Calendar.

    View SITC’s Cancer Immunotherapy Month Calendar.